BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 02:17 pm

Closure of Trading Window

Suven Life Sciences Ltd · 530239

✦ AI Summary

Suven Life Sciences Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective from 01 October 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30 September 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suven Life Sciences Ltd - 530239 - Closure of Trading Window

Attachments (1)

📄

ba3b80bc-531e-4594-9f69-9136dd4c2a40.pdf

pdf

Download →
View document text
CSD/BSE&NSE/TW/2026-27 Date: 28th September, 2026 To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Intimation of Closure of Trading Window Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading of designated persons, the ‘Trading Window’ for dealing in securities of the Company for all the designated persons and their immediate relatives, Connected Persons (including their relatives) as covered under the said code shall remain close with effect from 01 October, 2026, till the expiry of 48 hours after the declaration of unaudited Financial Results for the quarter and half year ended 30 September, 2026. Accordingly, all Designated Persons of the Company are being advised not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window. Please note that the date of Board Meeting for consideration and approval of unaudited financial results of the Company for quarter and half year ended September 30, 2026, shall be communicated in due course. This is for your information and records. Thanking you, Yours faithfully, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary & Compliance Officer Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com